Académique Documents
Professionnel Documents
Culture Documents
T HE PARTHENON G ROUP
Boston London Mumbai San Francisco
Agenda
Parthenon Global Healthcare Practice
Worldwide healthcare trends and investment implications Indias healthcare market
T HE P ARTHENON G ROUP
The Indian urban healthcare consumer New business models and investment opportunities
T HE P ARTHENON G ROUP
T HE P ARTHENON G ROUP
Built up from over 10 years of project experience Covering all major sectors of health care Advising on corporate and business unit strategies; policy and systems design; performance improvement; mergers and acquisitions
Suppliers
Laboratory
equipment
Life Sciences
Pharmaceuticals Drug distribution Nutritional
supplements
Providers
Hospitals Primary care Specialist treatment
centers
Payers
Managed care Other health
insurance
Government
Healthcare funding Health policy and
strategy
Informatics
Medical publishing
and education
Pharmacy benefit
managers
Leveraged
procurement
Revenue cycle
management
Outsourced clinical
research
Diagnostics and
imaging
Public health
Temporary staffing
Agenda
Parthenon Global Healthcare Practice
Worldwide healthcare trends and investment implications Indias healthcare market
T HE P ARTHENON G ROUP
The Indian urban healthcare consumer New business models and investment opportunities
T HE P ARTHENON G ROUP
15%
10%
6,000
Luxembourg
5,000
Switzerland Norway
4,000
3,000
2,000
Denmark Canada France Austria Germany Netherlands Australia Sweden Greece Ireland New Zealand Italy UK Israel Japan Finland Portugal Spain Argentina Qatar Singapore UAE Kuwait Brunei
5%
Hungary S. Africa Lithuania S. Korea Brazil Slovakia Poland Estonia 1,000 Turkey Latvia China Mexico Saudi India Russia Arabia
Policy trends are changing the healthcare landscape to try to bend the cost curve
Current Model Current Model
Performance
T HE P ARTHENON G ROUP
Activity
Treatment Inpatient Capital
Outcomes
Prevention Outpatient Information
T HE P ARTHENON G ROUP
Divest
Hold
Invest
Retail medicine / pharmacies Clinical labs Generic pharma Biotech Outsourced pharma services Contract research Contract manufacture Single speciality hospitals Medical Tourism Mental Health
TeleHealth
Wellness and prevention Obesity Smoking cessation Healthcare IT Decision support Revenue cycle management Outsourced Provider Services
Note: The segments in bold are of particular interest to the Indian market
Agenda
Parthenon Global Healthcare Practice
Worldwide healthcare trends and investment implications Indias healthcare market
T HE P ARTHENON G ROUP
The Indian urban healthcare consumer New business models and investment opportunities
T HE P ARTHENON G ROUP
Rs.1,943B
Rs.1,000B
Rs.893B
Rs.1,027B
Private
15%
Rs.0B
2000
2001
2002
2003
2004
2005
2006
2007
2008
% of GDP
4.3%
4.6%
4.8%
4.8%
4.9%
5.0%
4.9%
4.9%
4.9%
10
Out of pocket payment and private provision dominate Indias healthcare system
Rs.617B Rs.57B Rs.1,732B
T HE P ARTHENON G ROUP
Rs.168B
PMI & Other Pvt. Sources
Total = Rs.2,574B
Payer
Public
NGO & Social Security Contrib.
Out of Pocket
100%
Rs.203B
Public 80%
Provider
60%
Private
Private
Private
Public
Private
Source: World Health Report 2009, IBEF Healthcare Report 2009, Analyst Reports, Parthenon Analysis, Primary Research
11
The private market is highly fragmented and focused on acute care and pharmaceuticals
T HE P ARTHENON G ROUP
PMI 2009
100%
Rs.66B
Other
IFFCO TOKIO Cholamandalam
Reliance
Bajaj Allianz
80%
80%
Oriental
Star Health
60%
Other
Vimta Advinus Sai Advantium GVK
Zydus Cadila healthcare Aurobindo pharma
National
United India
40%
ICICI Lombard
20%
New India
0%
Ranbaxy
Primary Care
0%
Source: Assocham Healthcare Report 2009, Analyst Reports, Health Insurance India, IBEF Healthcare Report 2009, Primary Research
12
Acute care provision is highly concentrated at the high income end of Tier I cities
T HE P ARTHENON G ROUP
Hospital Beds per 10,000 Members of The Population Vis-a-Vis WHO Benchmarks, All-India and Tier I Cities
50
45
40 WHO recommended 30
20 15 10 10 7
18
All-India
<Rs 1K
Rs1-2K
Rs 2-4K
>Rs 4K
13
Note: Tier I is the average of Mumbai, New Delhi, and Bangalore Source: WHO, Primary Research
T HE P ARTHENON G ROUP
1.5X
1.0X
Health Expenditure
0.5X UK India - Urban
0.0X
High Income
Low Income
Income Level
Source: Fiscal Studies, Indicus Analytics, National Bureau of Statistics of the Peoples Republic of China, ONS
14
Agenda
Parthenon Global Healthcare Practice
Worldwide healthcare trends and investment implications Indias healthcare market
T HE P ARTHENON G ROUP
The Indian urban healthcare consumer New business models and investment opportunities
15
In urban India, the highest income segment accounts for les than 5% of households...
Tier I, Tier II & Tier III City Household Distribution By Annual Household Income Segments, 2008
100% 13M >1000K
500-1000K
T HE P ARTHENON G ROUP
9M
>1000K
6M
>1000K
Total = 28M *
500-1000K
300-500K
500-1000K 300-500K
80%
Percent of Households
300-500K 60%
<300K
<300K
0%
Tier I
Tier II
Tier III
Note: *48 districts out of 135 districts in Tier I, II or III are sampled Source: Primary Research, Parthenon Analysis, Indicus Analytics
16
T HE P ARTHENON G ROUP
Tier I, Tier II & Tier III City Healthcare Spending Distribution By Annual Household Income Segments, 2008
100%
80%
>1000K
>1000K
>1000K
Rs.69K
500-1000K
500-1000K 300-500K
Rs.18K
300-500K 300-500K
Rs.6.4K
20% <300K 0%
<300K
<300K
Rs.4.5K
Tier 1
Tier 2
Tier 3
Note: Income is annual disposable household income Source: Primary Research and Analysis, Indicus Analytics
17
T HE P ARTHENON G ROUP
Tier I, Tier II & Tier III City Healthcare Spending Distribution By Annual Household Income Segments, 2008
100%
80%
>1000K
>1000K
>1000K
Population Growth
~0% 0-10%
500-1000K
500-1000K
10-20%
>20%
300-500K 300-500K
300-500K
20% <300K
<300K
<300K
0%
Tier 1
Tier 2
Tier 3
Note: Income is annual disposable household income Source: Primary Research and Analysis, Indicus Analytics
18
T HE P ARTHENON G ROUP
62%
Percent of Respondents
60%
Percent Spent Money
51% 51% 48% 44%
40%
25%
22%
20%
0%
X-ray/ Specialist Antibiotics Ayurdevic Vaccination Small Hospital Ultrasound Visit Medicine Surgical Stay for Procedure Infection
GP Visit
Q: Have you or your family spent money in the last three years on the following healthcare categories? Source: Parthenon Healthcare Survey (n=105)
19
Dissatisfaction levels with hospital care are high, particularly with smaller and government hospitals
T HE P ARTHENON G ROUP
50%
10%
0%
Government Hospital
Corporate/Trust Hospital
Q: On a scale of 1-7 where 1 = Not at all satisfied and 7 = Extremely satisfied; how satisfied were you with your hospital stay? Source: Percent lower than 4, Parthenon Healthcare Survey (n=105)
20
Hygiene and staff quality dominate concerns at the low end; pricing and admin at the high end
T HE P ARTHENON G ROUP
100%
n=20 Other Quality of the Food Price of the Room per Night Billing and Admin. Process
80%
Waiting Times Waiting Times 20% Quality of the Nursing Staff 0% Government Hospital Private Small Hospital (<200 beds) Quality of the Nursing Staff Hygiene in the Hospital
Q: What were the three most important reasons for not being satisfied with your hospital stay? Source: Parthenon Healthcare Survey (n=105)
21
Tier 2 and middle income markets offer attractive opportunities alongside the traditional high end focus
Opportunity Attractiveness High Low
T HE P ARTHENON G ROUP
Tier 1
Tier II
Tier III
High Income
Middle Income
Lower Income
Expanding from High Income Tier 1 provision and to include Middle Income across other major urban areas, provides ~2.2X market opportunity also allowing a move away from highly competitive Tier 1 dynamics
22
Agenda
Parthenon Global Healthcare Practice
Worldwide healthcare trends and investment implications Indias healthcare market
T HE P ARTHENON G ROUP
The Indian urban healthcare consumer New business models and investment opportunities
23
Several business models offer attractive growth and lower capital intensity
Business Model Investment Thesis
T HE P ARTHENON G ROUP
India Examples
Specialist hospitals
Day surgeries
CapEx and star physicians by effectively extending the catchment area of the hospital In addition referrals pattern to hub is locked in
24
Several business models offer attractive growth and lower capital intensity
Business Model Investment Thesis
T HE P ARTHENON G ROUP
India Examples
Diagnostic clinics
Primary care
networks
Global CRO
services
Low cost trial capacity Cross-country capacity Access to patients and speed of recruitment High quality physicians and administrators Strong regulatory capabilities
25
Conclusion
India healthcare is an attractive growth market
T HE P ARTHENON G ROUP
It shares many of the characteristics of a luxury good, driven strongly by increases in disposable income
While its traditional focus has been on the high income segment in the metro areas,
around scale / price points make traditional high capital solutions difficult
Business models providing lower cost, improved CapEx leverage, greater operating
efficiency and / or addressing untapped markets are potential new horizons for
attractive healthcare investments
26